The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of somatic mutations on recurrence free survival (RFS) and overall survival (OS) for resected non-small cell lung cancer (NSCLC): results from the Japan Molecular Epidemiology for lung cancer study (JME).
 
Akihiro Tamiya
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb Japan; Ono Pharmaceutical
 
Yasuhiro Koh
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical; Thermo Fisher Scientific; Tosoh Corporation
Consulting or Advisory Role - Tosoh Corporation
Research Funding - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
 
Akihito Kubo
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Lilly Japan; Novartis; Taiho Pharmaceutical
Research Funding - Boehringer Ingelheim; Chugai Pharma; Lilly Japan
 
Masahiko Ando
No Relationships to Disclose
 
Shun-ichi Isa
No Relationships to Disclose
 
Hideo Saka
No Relationships to Disclose
 
Naoki Yoshimoto
No Relationships to Disclose
 
Masakuni Serizawa
No Relationships to Disclose
 
Sadanori Takeo
No Relationships to Disclose
 
Hirofumi Adachi
No Relationships to Disclose
 
Tsutomu Tagawa
No Relationships to Disclose
 
Osamu Kawashima
No Relationships to Disclose
 
Motohiro Yamashita
No Relationships to Disclose
 
Kazuhiko Kataoka
No Relationships to Disclose
 
Yukito Ichinose
Honoraria - Chugai Pharma
 
Yukiyasu Takeuchi
No Relationships to Disclose
 
Katsuya Watanabe
No Relationships to Disclose
 
Akihide Matsumura
No Relationships to Disclose
 
Tomoya Kawaguchi
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma
Research Funding - AstraZeneca; Boehringer Ingelheim; Chugai Pharma